Supplier
PHOENIX OCP
SAINT OUEN CEDEX · FRA
Track this recordFree account — get alerted when a contract here runs out.
Awards
13
Total awarded
€60.8m
13 / 13 with a value
Buyers
2
Sectors
1
Group: PHOENIX(inferred)
Reg. 58213743600660
Contracts this supplier holds that are running out
- 2 Sept 2027estimatedMARCHE SPECIFIQUE 2026 POUR L’ACHAT DE PRODUITS DU DOMAINE PHARMACEUTIQUE AUPRES D’UN GROSSISTE-REPARTITEURCentre Hospitalier de ValenciennesPHOENIX OCP€53,890,720
- 30 Apr 2029statedLOT 1 - A03FA01 - METOCLOPRAMIDE INJECTABLEGIP RESAHPHOENIX OCP€2,340,087
- 30 Apr 2029statedLOT 9 - A11HA02 - VITAMINE B6 (PYRIDOXINE) INJECTABLEGIP RESAHPHOENIX OCP€1,645,838
- 30 Apr 2029statedLOT 13 - B05XA02 - BICARBONATE DE SODIUM 1,4% AMPOULE VERRE INJECTABLEGIP RESAHPHOENIX OCP€61,125
- 30 Apr 2029statedLOT 14 - B05XA02 - BICARBONATE DE SODIUM AMPOULE VERRE INJECTABLEGIP RESAHPHOENIX OCP€144,839
- 30 Apr 2029statedLOT 15 - B05XA05 - SULFATE DE MAGNESIUM 10 % AMPOULE VERRE INJECTABLEGIP RESAHPHOENIX OCP€181,139
- 30 Apr 2029statedLOT 16 - B05XA07 - CHLORURE DE CALCIUM 10 % AMPOULE INJECTABLEGIP RESAHPHOENIX OCP€422,444
- 30 Apr 2029statedLOT 17 - B05XA11 - CHLORURE DE MAGNESIUM 10% AMPOULE VERRE INJECTABLEGIP RESAHPHOENIX OCP€719,154
- 30 Apr 2029statedLOT 19 - C01CA24 - ADRENALINE AMPOULE FAIBLES DOSAGESGIP RESAHPHOENIX OCP€154,854
- 30 Apr 2029statedLOT 22 - C03CA01 - FUROSEMIDE 250 MG INJECTABLEGIP RESAHPHOENIX OCP€657,034
- 30 Apr 2029statedLOT 37 - N02AA01 - MORPHINE 001 MG INJECTABLE (SANS CONSERVATEUR)GIP RESAHPHOENIX OCP€127,116
- 30 Apr 2029statedLOT 39 - N02AA01 - MORPHINE 20MG INJECTABLEGIP RESAHPHOENIX OCP€17,618
- 30 Apr 2029statedLOT 40 - N05BB01 - HYDROXYZINE INJECTABLEGIP RESAHPHOENIX OCP€388,626